Anna V. Roschke

2.5k total citations
27 papers, 1.9k citations indexed

About

Anna V. Roschke is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Anna V. Roschke has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Oncology. Recurrent topics in Anna V. Roschke's work include Genomic variations and chromosomal abnormalities (8 papers), DNA Repair Mechanisms (6 papers) and Microtubule and mitosis dynamics (6 papers). Anna V. Roschke is often cited by papers focused on Genomic variations and chromosomal abnormalities (8 papers), DNA Repair Mechanisms (6 papers) and Microtubule and mitosis dynamics (6 papers). Anna V. Roschke collaborates with scholars based in United States, Italy and United Kingdom. Anna V. Roschke's co-authors include Ilan R. Kirsch, Giovanni Tonon, David H. Ledbetter, John N. Weinstein, Samir Lababidi, W. Michael Kuehl, Kristen Gehlhaus, P. Leif Bergsagel, Leslie A. Brents and Kimberly J. Bussey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Genetics.

In The Last Decade

Anna V. Roschke

27 papers receiving 1.9k citations

Peers

Anna V. Roschke
Blanca Scheijen Netherlands
Jana Karásková Canada
Yoshihiro Takihara Japan
Zoë Weaver Ohler United States
Kirk J. McManus Canada
Karl Dykema United States
Elena Díaz‐Rodríguez Spain
Qunyan Yu United States
Chi Wai Eric So United Kingdom
Tamar Uziel United States
Blanca Scheijen Netherlands
Anna V. Roschke
Citations per year, relative to Anna V. Roschke Anna V. Roschke (= 1×) peers Blanca Scheijen

Countries citing papers authored by Anna V. Roschke

Since Specialization
Citations

This map shows the geographic impact of Anna V. Roschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna V. Roschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna V. Roschke more than expected).

Fields of papers citing papers by Anna V. Roschke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna V. Roschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna V. Roschke. The network helps show where Anna V. Roschke may publish in the future.

Co-authorship network of co-authors of Anna V. Roschke

This figure shows the co-authorship network connecting the top 25 collaborators of Anna V. Roschke. A scholar is included among the top collaborators of Anna V. Roschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna V. Roschke. Anna V. Roschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yost, Kathryn E., Sarah F. Clatterbuck Soper, Robert L. Walker, et al.. (2019). Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells. Scientific Reports. 9(1). 4544–4544. 34 indexed citations
2.
Qiu, Zhi‐Jun, Zhenhua Zhang, Anna V. Roschke, Tamás Varga, & Peter D. Aplan. (2017). Generation of Gross Chromosomal Rearrangements by a Single Engineered DNA Double Strand Break. Scientific Reports. 7(1). 43156–43156. 5 indexed citations
3.
Rozenblum, Ester, José Sotelo‐Silveira, Jack Zhu, et al.. (2017). Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumor. PLoS ONE. 12(8). e0182610–e0182610. 1 indexed citations
4.
Demchenko, Yulia N., Anna V. Roschke, Wei-Dong Chen, et al.. (2016). Frequent occurrence of large duplications at reciprocal genomic rearrangement breakpoints in multiple myeloma and other tumors. Nucleic Acids Research. 44(17). 8189–8198. 8 indexed citations
5.
Affer, Maurizio, Marta Chesi, Jonathan J. Keats, et al.. (2014). Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. Leukemia. 28(8). 1725–1735. 181 indexed citations
6.
Roschke, Anna V. & Ester Rozenblum. (2013). Multi-Layered Cancer Chromosomal Instability Phenotype. Frontiers in Oncology. 3. 302–302. 25 indexed citations
7.
Rozenblum, Ester, O K Glebov, Robert L. Walker, et al.. (2013). Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines. Cancer Genetics. 206(5). 191–205. 21 indexed citations
8.
Roschke, Anna V. & Ilan R. Kirsch. (2010). Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells. Current Drug Targets. 11(10). 1341–1350. 35 indexed citations
9.
Cheng, Yue, Zhenhua Zhang, Bridget P. Keenan, et al.. (2009). Efficient repair of DNA double-strand breaks in malignant cells with structural instability. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 683(1-2). 115–122. 9 indexed citations
10.
11.
Gabrea, Ana, Marialuisa Martelli, Ying Qi, et al.. (2008). Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors. Genes Chromosomes and Cancer. 47(7). 573–590. 63 indexed citations
12.
Lenz, Georg, Inga Nagel, Reiner Siebert, et al.. (2007). Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma. The Journal of Experimental Medicine. 204(3). 633–643. 139 indexed citations
13.
Wallqvist, Anders, et al.. (2005). Drugs aimed at targeting characteristic karyotypic phenotypes of cancer cells. Molecular Cancer Therapeutics. 4(10). 1559–1568. 15 indexed citations
14.
Roschke, Anna V. & Ilan R. Kirsch. (2005). Targeting Cancer Cells by Exploiting Karyotypic Complexity and Chromosomal Instability. Cell Cycle. 4(5). 679–682. 23 indexed citations
15.
Reinhold, William C., Hosein Kouros‐Mehr, Kurt W. Kohn, et al.. (2003). Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.. PubMed. 63(5). 1000–11. 49 indexed citations
16.
17.
Blegen, Harald, N. Einhorn, K. Sjövall, et al.. (2000). Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas. International Journal of Gynecological Cancer. 10(6). 477–487. 38 indexed citations
18.
Chong, Samuel S., Svetlana Pack, Anna V. Roschke, et al.. (1997). A Revision of the Lissencephaly and Miller-Dieker Syndrome Critical Regions in Chromosome 17p13.3. Human Molecular Genetics. 6(2). 147–155. 153 indexed citations
19.
Ning, Yi, et al.. (1996). Identification of a novel paternally expressed transcript adjacent to snRPN in the Prader-Willi syndrome critical region.. Genome Research. 6(8). 742–746. 22 indexed citations
20.
Chong, Samuel S., Akira Tanigami, Anna V. Roschke, & David H. Ledbetter. (1996). 14-3-3 epsilon has no homology to LIS1 and lies telomeric to it on chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome region.. Genome Research. 6(8). 735–741. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Blanca Scheijen Breakdown of academic impact, for papers by Jana Karásková Breakdown of academic impact, for papers by Yoshihiro Takihara Breakdown of academic impact, for papers by Zoë Weaver Ohler Breakdown of academic impact, for papers by Kirk J. McManus Breakdown of academic impact, for papers by Karl Dykema Breakdown of academic impact, for papers by Elena Díaz‐Rodríguez Breakdown of academic impact, for papers by Qunyan Yu Breakdown of academic impact, for papers by Chi Wai Eric So Breakdown of academic impact, for papers by Tamar Uziel
Rankless by CCL
2026